Denial - I get what you're saying but my point is that until there is a statistically significant result - those "averages" are just down to chance and can be just down to luck and randomisation. While some people may still believe there to be a DMOAD benefit, the drug label and therefore partners will not / they can't.
As for your second question re professional indemnity. It's the same result as above. It's a moot point unless you can get something on a label, but if you are talking purely on pain and function which PPS at least seems to have some evidence of (mind you in a smaller population ((mild to mid pain patients only)), then yeah sure - but then you're just competing in a low price arena against $1 tablets which are easily prescribed and dispensed versus an injectable multiple times a week and requiring physician visits. Further to this, I personally haven't seen any studies proving that these other drugs (NSAIDS, OPIOIDS, HA, etc etc) accelerates the underlying pathology on a long-term basis aside from what mgmt have said.
- Forums
- ASX - By Stock
- Community Adoption / Mr Federer
Denial - I get what you're saying but my point is that until...
-
-
- There are more pages in this discussion • 40 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PAR (ASX) to my watchlist
|
|||||
Last
24.5¢ |
Change
-0.005(2.00%) |
Mkt cap ! $85.70M |
Open | High | Low | Value | Volume |
25.0¢ | 25.5¢ | 24.0¢ | $187.1K | 755.0K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 47906 | 24.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
25.0¢ | 13363 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 47906 | 0.245 |
3 | 82048 | 0.240 |
2 | 32293 | 0.235 |
8 | 110599 | 0.230 |
7 | 89672 | 0.225 |
Price($) | Vol. | No. |
---|---|---|
0.250 | 13363 | 1 |
0.255 | 34148 | 4 |
0.260 | 6415 | 2 |
0.270 | 19081 | 2 |
0.275 | 13636 | 2 |
Last trade - 16.10pm 11/09/2024 (20 minute delay) ? |
Featured News
PAR (ASX) Chart |